REUTERS/Brendan McDermid/File Photo The company in 2016 also agreed to buy Alere Inc ALR.N for $5.8 billion and to sell its medical optics division to Johnson & Johnson JNJ.N for $4.3 billion as it sheds its slow-growth, low-margin businesses and fortifies its presence in cardiovascular devices and diagnostics.